WideMed recently won EU CE Mark certification for its Morpheus products line.
WideMed Ltd. (TASE:WDMD) has launched European sales of its sleep disorder diagnostic device, Morpheus Hx. GE Healthcare placed its first order for the device for the UK market, after WideMed conducted a training seminar for GE Healthcare UK and Irish sales reps in November.
WideMed received EU CE Mark certification for its Morpheus products line in September, and earlier expanded its sales and distribution agreement with GE Healthcare in Europe. GE Healthcare has already bought ten Morpheus Hx devices.
WideMed's share price rose 2.5% in morning trading to NIS 1.15, giving a market cap of NIS 19 million.
Published by Globes [online], Israel business news - www.globes-online.com - on December 19, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010